S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts

$25.70
-0.23 (-0.89%)
(As of 04/15/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 8Estimated
Actual EPS
(Feb. 27)
$1.73 Beat By $2.42
Consensus EPS
(Feb. 27)
-$0.69
Skip Charts & View Estimated and Actual Earnings Data

BEAM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BEAM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Beam Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($1.31)($1.18)($1.26)
Q2 20243($1.36)($1.18)($1.26)
Q3 20243($1.33)($1.18)($1.25)
Q4 20243($1.33)($1.17)($1.23)
FY 202412($5.33)($4.71)($5.00)
Q1 20251($1.35)($1.35)($1.35)
Q2 20251($1.28)($1.28)($1.28)
Q3 20251($1.19)($1.19)($1.19)
Q4 20251($1.19)($1.19)($1.19)
FY 20254($5.01)($5.01)($5.01)

BEAM Earnings Date and Information

Beam Therapeutics last posted its quarterly earnings results on February 27th, 2024. The reported $1.73 earnings per share for the quarter, beating analysts' consensus estimates of ($0.69) by $2.42. The business earned $316.20 million during the quarter, compared to the consensus estimate of $34.16 million. Its revenue was up 1481.0% on a year-over-year basis. Beam Therapeutics has generated ($1.90) earnings per share over the last year (($1.90) diluted earnings per share). Earnings for Beam Therapeutics are expected to grow in the coming year, from ($5.53) to ($5.04) per share. Beam Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.

Beam Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Estimated)
------- 
2/27/2024Q4 2023($0.69)$1.73+$2.42$1.73$34.16 million$316.20 million
11/8/2023Q3 2023($1.33)($1.22)+$0.11($1.22)$17.09 million$17.20 million    
8/8/2023Q2 2023($1.42)($1.08)+$0.34($1.08)$17.32 million$20.12 million
5/10/2023Q1 2023($1.36)($1.33)+$0.03($1.33)$14.41 million$24.21 million
2/28/2023Q4 2022($1.34)($0.54)+$0.80($0.54)$12.73 million$20.04 million
11/7/2022Q3 2022($1.30)($1.56)($0.26)($1.56)$7.15 million$15.80 million
8/9/2022Q2 2022($1.08)($1.02)+$0.06($1.02)$9.44 million$16.65 million
5/9/2022Q1 2022($1.10)($1.01)+$0.09($1.01)$44.15 million$8.40 million
2/28/2022Q4 2021($1.02)($0.85)+$0.17($0.75)$9.58 million$51.07 million    
11/7/2021Q3 2021($0.72)($0.42)+$0.30($0.42)$15.88 million$0.76 million
8/9/2021Q2 2021($0.74)($1.23)($0.49)($0.67)$8.33 million$0.01 million
5/10/2021Q1 2021($0.74)($3.35)($2.61)($3.35)$6.00 million$0.01 million

Beam Therapeutics Earnings - Frequently Asked Questions

When is Beam Therapeutics's earnings date?

Beam Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on BEAM's earnings history.

Did Beam Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Beam Therapeutics (NASDAQ:BEAM) reported $1.73 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.69) by $2.42. Learn more on analysts' earnings estimate vs. BEAM's actual earnings.

How much revenue does Beam Therapeutics generate each year?

Beam Therapeutics (NASDAQ:BEAM) has a recorded annual revenue of $377.71 million.

How much profit does Beam Therapeutics generate each year?

Beam Therapeutics (NASDAQ:BEAM) has a recorded net income of -$132.53 million. BEAM has generated -$1.90 earnings per share over the last four quarters.

What is Beam Therapeutics's EPS forecast for next year?

Beam Therapeutics's earnings are expected to grow from ($5.53) per share to ($5.04) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:BEAM) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners